
[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)]
[Notices]
[Pages 57094-57095]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22784]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-0881]


Draft Guidance for Industry on Self-Identification of Generic 
Drug Facilities, Sites, and Organizations; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Monday, August 27, 2012 (77 FR 
51811). The document announced a draft guidance for industry entitled 
``Self-Identification of Generic Drug Facilities, Sites, and 
Organizations.'' The document was published with an incorrect docket

[[Page 57095]]

number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, 
Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2012-20946, appearing on page 
51811 in the Federal Register of Monday, August 27, 2012, the following 
correction is made:
    1. On page 51811, in the third column, the docket number is 
corrected to read ``FDA-2012-D-0881''.

    Dated: August 30, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-22784 Filed 9-14-12; 8:45 am]
BILLING CODE 4160-01-P


